Furthermore, in prostate cancer, the high expression of sdRNA‐D19b and sdRNA‐A24 enhances prostate cancer cell proliferation, metastatic ability, and resistance to chemotherapy by regulating the expression of CD44 and CDK12.39 The gene discussed is CD44; the disease is prostate cancer.